BRITTANY NGUYEN: Open Payments
NPI 1932608809 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 23 payments from 8 companies in 2025. Trend: 2023 $488 · 2024 $349 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| MILLICENT US INC | 7 | $138 |
| Sumitomo Pharma America, Inc. | 5 | $89 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $66 |
| Hologic Sales and Service, LLC | 1 | $28 |
| ABBVIE INC. | 1 | $24 |
| Acella Pharmaceuticals, LLC | 1 | $19 |
| Exeltis, USA Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
Products named: MYFEMBREE, INTRAROSA, FEMLYV, APTIMA, ORILISSA, NP Thyroid 60, SLYND, Wegovy.
Industry payments across AL — which companies pay providers there.
